Clinical Trials
14 trialsNCT04749394 2022-08-16
A Study of Camrelizumab Plus Apatinib as Consolidation Therapy in Non-Small Cell Lung Cancer Patients Treated With Chemoradiotherapy
ChineseAMS
Phase 2 Unknown
NCT04762459 2022-02-24
APEX
ChineseAMS
Phase 3 Enrolling by invitation
NCT00880971 2020-10-05
Postoperative Radiotherapy for Patients With IIIA (N2) Non-small Cell Lung Cancer
ChineseAMS
Phase 3 Completed
NCT02346955 2020-08-27
MK-6018-001
KitovPharma
Phase 1 Terminated
NCT04304638 2020-03-11
Real-world Treatment Patterns and Clinical Outcomes in EGFR-mutant Unresectable Locally Advanced NSCLC
ChineseAMS
Unknown
NCT03916913 2019-04-17
TKI Followed by Thoracic Radiotherapy for Stage IV EGFR Mutant NSCLC
ChineseAMS
Phase NA Unknown
NCT02960607 2016-11-18
High-dose Icotinib Treatment Beyond Progression in EGFR Mutant NSCLC
ChineseAMS
Phase 2 Unknown
NCT02961270 2016-11-11
Icotinib in Non-small Cell Lung Cancer Patients With Uncommon EGFR Mutation
ChineseAMS
Phase 2 Unknown
NCT02584699 2015-10-23
Study of Stereotactic Ablative Radiotherapy (SABR) in Elderly Stage I NSCLC
ChineseAMS
Phase 2 Unknown
NCT00600587 2013-06-25
Induction Erlotinib Therapy in Stage III A (N2) Non-Small Cell Lung Cancer (NSCLC)
GuangdongPPH
Phase 2 Completed
NCT01850147 2013-05-09
Sequential Use of Low-dose Sunitinib With Chemotherapy in Advanced NSCLC After Failure of Conventional Regimen
ChineseAMS
Phase 2 Unknown
NCT01494558 2011-12-19
Study of Etoposide, Cisplatin, and Radiotherapy Versus Paclitaxel, Carboplatin and Radiotherapy to Treat Non-Small Cell Lung Cancer
ChineseAMS
Phase 2/3 Completed
NCT00663689 2008-04-22
Efficacy of Erlotinib for Brain Metastasis of Non-Small Cell Lung Cancer
GuangdongPPH
Phase 2 Unknown
NCT00614809 2008-02-22
Efficacy of Gefitinib for Brain Metastasis of Non-Small Cell Lung Cancer
GuangdongPPH
Phase 2 Unknown